Scientist I, Drug Product Analytics (Laboratory Automation)

Vaxcyte

Where
San Carlos, California, United States
Pay
$129K to $151K a year

Posted 45 days ago· Checked live at Vaxcyte 3 hours ago

Stale: open 45 daysUp for more than two weeks. It may already be filled.

See how you score for this job

One sentence and your resume. We score it against what Vaxcyte asks for, line by line.

See my score
Is this job still open?
Yes. We checked it live on Vaxcyte's own hiring page 3 hours ago.
What is the job?
Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning.
What does it pay?
$129K to $151K a year, as the posting states.
Our verdict
Stale. Up for more than two weeks. It may already be filled.

What the job is

Join our Mission to Protect Humankind!

Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning.

Requirements

  • PhD, MS or Bachelor’s degree in Chemistry, Biochemistry, Biology, Pharmaceutical Sciences, or a related scientific discipline. PhD with 0-2 years; MS with 5+ years; BS with 8+ years of relevant industry experience. Other combinations of education and/or experience may be considered. Candidates at the Senior Research Associate level with strong laboratory automation experience are also encouraged to apply. Other combinations of education and/or experience may be considered.
  • Hands-on experience developing and programming methods on automated liquid handling platforms, with Hamilton (VENUS software) strongly preferred (experience with Tecan, Beckman, or comparable systems will be considered), including building, optimizing, and validating automated assay workflows.
  • Demonstrated programming and scripting ability (e.g., Hamilton VENUS, Python, VBA, or equivalent) to build automated workflows, integrate instrumentation, and support data handling — with the ability to independently troubleshoot robotic hardware and liquid-handling errors.
  • Hands-on experience developing, optimizing, and executing ELISA or multiplex immunoassays (MSD preferred) with demonstrated ability to troubleshoot assay performance and interpret assay data.
  • Experience supporting or leading method transfer, method bridging, or comparability assessments, including associated study design and statistical data analysis.
  • Familiarity with plate-based assays (Lowry, BCA, etc.), multiplexed immunoassays (MSD).
  • Experience analyzing and visualizing assay data using software tools such as Excel, Prism, or equivalent statistical/data analysis platforms.
  • Experience authoring analytical technical documentation including method protocols, SOPs, reports, and study summaries, and maintaining well-documented electronic laboratory notebooks (eLN).
  • Strong organizational skills and the ability to manage multiple projects and shifting priorities in a dynamic development environment.
  • Strong interpersonal and communication skills, with the ability to effectively collaborate across teams and train or mentor junior analysts when needed.
  • Detail-oriented with a high level of scientific rigor and excellence in data integrity and record keeping.

Reports to: Associate Director, Drug Product Analytics

Location: San Carlos, CA

Work Arrangement (may be adjusted based on business needs, job responsibilities, or changes to company policy):

Onsite (minimum of 4 days per week onsite)

Compensation

The compensation package will be competitive and includes comprehensive benefits and an equity component.